Skip to content

HIPPO study - Happiness for Improvement of Premature and Parental Outcome

HIPPO study - Happiness for Improvement of Premature and Parental Outcome Understanding the consequences of stress after preterm birth in a national cohort study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON22163
Enrollment
400
Registered
2020-10-02
Start date
2020-07-14
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

preterm birth

Interventions

None

Sponsors

Erasmus Medical Center
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: - Gestational age below 29 0/7 weeks - Signed agreement of participation and use of data from both parents or guardians

Exclusion criteria

Exclusion criteria: Because the questionnaires for parents will only be available in Dutch and English, parents that insufficiently understand these languages to fill in the questionnaires will be excluded from this part of the study. However, if they are able to read the patient information folder (in Dutch or English) they will not be excluded from the data collection regarding their child and the collection of biomaterial for both the infant and his/her parents.

Design outcomes

Primary

MeasureTime frame
Main study parameter is the exposure to stress and level of comfort during the NICU admission for both the parents and the infant. Next to this, residual body material will be collected to analyse biochemical and epigenetic changes in the neonate during neonatal life. Data regarding stress and comfort during the prenatal, perinatal and neonatal period will be related to short- and long-term outcome obtained by the national standard of care follow-up program

Secondary

MeasureTime frame
Long term follow-up (tbd)

Contacts

Public ContactSinno Simons

Erasmus MC - Sophia

s.simons@erasmusmc.nl0031641376695

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)